Technical Analysis for VCYT - Veracyte, Inc.

Grade Last Price % Change Price Change
D 49.18 -0.43% -0.21
VCYT closed down 0.43 percent on Thursday, April 22, 2021, on 59 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical VCYT trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
200 DMA Support Bullish -0.43%
Lower Bollinger Band Walk Weakness -0.43%
Lower Bollinger Band Touch Weakness -0.43%
Crossed Above 200 DMA Bullish 6.98%
Lower Bollinger Band Walk Weakness 6.98%
Stochastic Reached Oversold Weakness 6.98%
Inside Day Range Contraction 6.98%
Older End-of-Day Signals for VCYT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 14 hours ago
Down 2 % about 14 hours ago
Possible NR7 about 14 hours ago
60 Minute Opening Range Breakout about 15 hours ago
Rose Above Previous Day's High about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Veracyte, Inc. Description

Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Telemedicine Telehealth Thyroid Gene Expression Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Lung Cancer Surgeries Metastases Thyroid Cancer Glands Healthcare Costs Thyroid Nodule Thyroid Nodules

Is VCYT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 86.03
52 Week Low 22.69
Average Volume 987,699
200-Day Moving Average 45.89
50-Day Moving Average 55.83
20-Day Moving Average 51.29
10-Day Moving Average 50.72
Average True Range 4.62
ADX 14.39
+DI 22.71
-DI 25.89
Chandelier Exit (Long, 3 ATRs ) 45.97
Chandelier Exit (Short, 3 ATRs ) 57.36
Upper Bollinger Band 57.95
Lower Bollinger Band 44.63
Percent B (%b) 0.34
BandWidth 25.97
MACD Line -1.53
MACD Signal Line -1.24
MACD Histogram -0.2902
Fundamentals Value
Market Cap 2.85 Billion
Num Shares 57.9 Million
EPS -0.29
Price-to-Earnings (P/E) Ratio -170.76
Price-to-Sales 24.96
Price-to-Book 7.55
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.77
Resistance 3 (R3) 52.79 51.61 52.17
Resistance 2 (R2) 51.61 50.70 51.60 51.97
Resistance 1 (R1) 50.40 50.14 49.81 50.38 51.77
Pivot Point 49.22 49.22 48.93 49.21 49.22
Support 1 (S1) 48.01 48.31 47.42 47.99 46.59
Support 2 (S2) 46.83 47.75 46.82 46.39
Support 3 (S3) 45.62 46.83 46.19
Support 4 (S4) 45.60